Source:http://linkedlifedata.com/resource/pubmed/id/20828557
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
2010-10-25
|
pubmed:abstractText |
Diabetic nephropathy is the most common cause of chronic kidney disease. We investigated the ability of intracellular galectin-1 (Gal-1), a prototype of endogenous lectin, to prevent renal fibrosis by regulating cell signaling under a high glucose (HG) condition. We demonstrated that overexpression of Gal-1 reduces type I collagen (COL1) expression and transcription in human renal epithelial cells under HG conditions and transforming growth factor-?1 (TGF-?1) stimulation. Matrix metalloproteinase 1 (MMP1) is stimulated by Gal-1. HG conditions and TGF-?1 treatment augment expression and nuclear translocation of Gal-1. In contrast, targeted inhibition of Gal-1 expression reduces COL1 expression and increases MMP1 expression. The Smad3 signaling pathway is inhibited, whereas two mitogen-activated protein kinase (MAPK) pathways, p38 and extracellular signal-regulated kinase (ERK), are activated by Gal-1, indicating that Gal-1 regulates these signaling pathways in COL1 production. Using specific inhibitors of Smad3, ERK, and p38 MAPK, we showed that ERK MAPK activated by Gal-1 plays an inhibitory role in COL1 transcription and that activation of the p38 MAPK pathway by Gal-1 plays a negative role in MMP1 production. Taken together, two MAPK pathways are stimulated by increasing levels of Gal-1 in the HG condition, leading to suppression of COL1 expression and increase of MMP1 expression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP...,
http://linkedlifedata.com/resource/pubmed/chemical/Galectin 1,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/SMAD3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Smad3 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/alpha 2(I) collagen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1090-2422
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
316
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3282-91
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20828557-Cell Line,
pubmed-meshheading:20828557-Collagen,
pubmed-meshheading:20828557-Collagen Type I,
pubmed-meshheading:20828557-Epithelial Cells,
pubmed-meshheading:20828557-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:20828557-Fibrosis,
pubmed-meshheading:20828557-Galectin 1,
pubmed-meshheading:20828557-Glucose,
pubmed-meshheading:20828557-Humans,
pubmed-meshheading:20828557-Kidney,
pubmed-meshheading:20828557-Matrix Metalloproteinase 1,
pubmed-meshheading:20828557-Models, Biological,
pubmed-meshheading:20828557-Protein Transport,
pubmed-meshheading:20828557-Smad3 Protein,
pubmed-meshheading:20828557-Transcription, Genetic
|
pubmed:year |
2010
|
pubmed:articleTitle |
Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells.
|
pubmed:affiliation |
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo 162-8666, Japan. kaokano@kc.twmu.ac.jp
|
pubmed:publicationType |
Journal Article
|